Related Experiment Videos
Embryonal carcinoma of the testis
Cancer
|June 1, 1988
Summary
Testicular embryonal carcinoma shows an 88% 5-year survival rate, with outcomes improving due to early detection and chemotherapy. Survival is linked to disease stage at diagnosis for these germ cell tumors.
Area of Science:
- Oncology
- Urology
- Pathology
Background:
- Embryonal carcinoma is an aggressive testicular germ cell tumor with a tendency for early metastasis.
- Endodermal sinus tumors are less common and primarily affect younger individuals.
Purpose of the Study:
- To correlate long-term survival rates with clinical features in patients diagnosed with testicular embryonal carcinoma and endodermal sinus tumors.
- To assess the impact of disease extent and treatment advancements on patient outcomes.
Main Methods:
- Retrospective analysis of 479 patients with embryonal carcinoma and 33 with endodermal sinus tumor.
- Correlation of survival data with clinical features, including age, disease stage at diagnosis, and treatment response.
Main Results:
- Overall 5-year survival for embryonal carcinoma was 88%, with rates of 98% (localized), 96% (regional), and 74% (distant) disease.
- Embryonal carcinoma predominantly affects males aged 15-34, with 74% presenting with metastatic disease.
- Endodermal sinus tumors had a slightly lower survival rate compared to embryonal carcinoma.
Conclusions:
- Survival for testicular embryonal carcinoma has significantly improved due to enhanced early detection of metastases and effective chemotherapy for disseminated disease.
- Treatment strategies and early diagnosis are critical for improving outcomes in patients with testicular germ cell tumors.